Georges Herbein

Head, Professor

Center For Biomarker Research In Medicine

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Georges Herbein is a Head Professor at the Apex Center for Medical Research in France. His research primarily focuses on the roles of human cytomegalovirus in cancer biology, particularly the formation and implications of polyploid giant cancer cells. Recent publications explore the interactions between cytomegalovirus and glioblastoma, as well as the management of epigenomic networks relevant to coronavirus infections and COVID-19.

Articles (9)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (1)

Joris Guyon

Associate Professor

Centre Hospitalier Universitaire Vaudois

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Georges Herbein

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Formation of polyploid giant cancer cells and the transformative role of human cytomegalovirus IE1 protein

Generation of glioblastoma in mice engrafted with human cytomegalovirus-infected astrocytes

Polyploidy, EZH2 upregulation, and transformation in cytomegalovirus-infected human ovarian epithelial cells

EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes

High-Risk Oncogenic Human Cytomegalovirus

Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus

Polyploid giant cancer cells, stemness and epithelial-mesenchymal plasticity elicited by human cytomegalovirus

Management of epigenomic networks entailed in coronavirus infections and COVID-19

Polyploid Giant Cancer Cells, a Hallmark of Oncoviruses and a New Therapeutic Challenge

Collaborators (1)

Joris Guyon

Make your next move.